SCHEMBL30815539

SCHEMBL30815539

C[Sn](C)(C)c1ccc([N+](=O)[O-])c(Nc2ccc(CO)cc2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MCL1 Q07820 1/20 0.41
▸ PTK2B Q14289 1/20 0.41
▸ MAPK1 P28482 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ GSK3B P49841 3/20 0.38
▸ HSF1 Q00613 1/20 0.38
▸ AURKA O14965 2/20 0.37
▸ GSK3A P49840 2/20 0.37
▸ BRD4 O60885 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27227241 1.00 MAPT (0.41) MAPTKMT2AMEN1CYP1A2CYP3A4
SCHEMBL27226907 0.84 MAPT (0.42) MAPTKMT2AMEN1CYP1A2CYP3A4
SCHEMBL27227041 0.81 MAPT (0.42) MAPTKMT2AMEN1CYP1A2CYP3A4
SCHEMBL27227145 0.81 MAPT (0.54) MAPTKMT2AMEN1CYP1A2CYP3A4
SCHEMBL27226191 0.81 MAPT (0.41) MAPTKMT2AMEN1CYP1A2CYP3A4
SCHEMBL27226838 0.81 MEN1 (0.51) MAPTKMT2AMEN1CYP1A2CYP3A4
SCHEMBL30815301 0.81 MEN1 (0.51) MAPTKMT2AMEN1CYP1A2CYP3A4
SCHEMBL27227025 0.80 TXNRD1 (0.46) MAPTKMT2AMEN1CYP1A2CYP3A4
SCHEMBL30815817 0.78 PTK2 (0.43) MAPTKMT2AMEN1CYP1A2CYP3A4
SCHEMBL30814928 0.78 MAPT (0.45) MAPTKMT2AMEN1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594318-A1 AKT1 MODULATORS Alterome Therapeutics, Inc. (US) 2025-08-06 — — EP disclosed
WO-2024073371-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback